Production/Supply Archives - Page 2 of 5 - EMEA

This site provides INTERCEPT product information for International audiences .

Production and in vitro quality of pooled whole blood derived PI plasma

Production and in vitro quality of pooled whole blood derived PI plasma

by jaycornell | May 5, 2025

Dr. sc. nat. David Goslings, MBA Blood Transfusion Service Zurich Zurich, Switzerland

Production and in vitro quality of pooled whole blood derived PI plasma

Production and in vitro quality of pooled whole blood derived PI plasma

by jaycornell | May 5, 2025

Dr. sc. nat. David Goslings, MBA Blood Transfusion Service Zurich Zurich, Switzerland

How pools-of-pools contributes to optimising your PI platelet products

How pools-of-pools contributes to optimising your PI platelet products

by jaycornell | May 5, 2025

Mr. Jean-Marc Payrat Cerus Europe B.V. Amersfoort, the Netherlands

Preparation and Pathogen Inactivation of Double Dose Buffy Coat Platelet Products Using the INTERCEPT Blood System

Preparation and Pathogen Inactivation of Double Dose Buffy Coat Platelet Products Using the INTERCEPT Blood System

by jaycornell | May 5, 2025

Dr. Mohammad R. Abedi, MD, PhD Örebro University Hospital Stockholm, Sweden

Pathogen reduction of double dose platelet concentrates from pools of eight Buffy coats: product quality, safety and economic aspects

Pathogen reduction of double dose platelet concentrates from pools of eight Buffy coats: product quality, safety and economic aspects

by jaycornell | May 5, 2025

Dr. Konrad Rosskopf Dept. Transfusion Medicine University Hospital of Graz, Austria

« Older Entries

Next Entries »